1Dept of Molecular Biology & Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. jef.boeke@qmail.bs.jhu.edu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers are developing antiviral fusion proteins to neutralize retroviral infectivity. These proteins, when incorporated into the virus, aim to be lethal to the virus while remaining non-toxic to the host cells.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: